Chicken Consumption and Use of Acid-suppressing Medications As Risk Factors for Campylobacter Enteritis, England

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2009 Oct 1

PMID 19788807

Citations 27

Authors

Clarence C Tam

Craig D Higgins

Keith R Neal

Laura C Rodrigues

Sally E Millership

Sarah J OBrien

Affiliations

Soon will be listed here.

Abstract

In a case-control study of Campylobacter spp. risk factors in England during 2005-2006, we identified recent consumption of commercially prepared chicken as an important risk factor. The risk for illness associated with recent chicken consumption was much lower for persons who regularly ate chicken than in those who did not, which suggests that partial immunologic protection may follow regular chicken preparation or consumption. Chicken-related risk factors accounted for 41% of cases; acid-suppressing medication, for 10%; self-reported past Campylobacter enteritis, 2%; and recent acquisition of a pet dog, 1%. Understanding the risks associated with chicken from different sources will benefit strategies to reduce Campylobacter infections. Better characterization of immune correlates for Campylobacter infection is necessary to assess the relative importance of immunity and behavioral factors in determining risk.

Citing Articles

Evaluation of a FlpA Glycoconjugate Vaccine with Ten -Heptasaccharide Glycan Moieties to reduce Colonisation in Chickens.

Corona-Torres R, Vohra P, Chintoan-Uta C, Bremner A, Terra V, Mauri M Vaccines (Basel). 2024; 12(4).

PMID: 38675777 PMC: 11054393. DOI: 10.3390/vaccines12040395.

Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival.

Kemper L, Hensel A Appl Microbiol Biotechnol. 2023; 107(9):2725-2754.

PMID: 36941439 PMC: 10027602. DOI: 10.1007/s00253-023-12456-w.

Prevalence and risk factors of bacterial enteric pathogens in men who have sex with men: A cross-sectional study at the UK's largest sexual health service.

Mitchell H, Whitlock G, Zdravkov J, Olsson J, Silalang P, Bardsley M J Infect. 2022; 86(1):33-40.

PMID: 36343788 PMC: 10564623. DOI: 10.1016/j.jinf.2022.10.033.

Occurrence of potentially zoonotic and cephalosporin resistant enteric bacteria among shelter dogs in the Central and South-Central Appalachia.

Verma A, Carney K, Taylor M, Amsler K, Morgan J, Gruszynski K BMC Vet Res. 2021; 17(1):313.

PMID: 34563197 PMC: 8467218. DOI: 10.1186/s12917-021-03025-2.

Evaluation of Glycosylated FlpA and SodB as Subunit Vaccines Against Colonisation in Chickens.

Vohra P, Chintoan-Uta C, Terra V, Bremner A, Cuccui J, Wren B Vaccines (Basel). 2020; 8(3).

PMID: 32932979 PMC: 7564835. DOI: 10.3390/vaccines8030520.

References

Neal K, Slack R . Diabetes mellitus, anti-secretory drugs and other risk factors for campylobacter gastro-enteritis in adults: a case-control study. Epidemiol Infect. 1998; 119(3):307-11. PMC: 2809002. DOI: 10.1017/s0950268897008224. View

Evans M, Ribeiro C, Salmon R . Hazards of healthy living: bottled water and salad vegetables as risk factors for Campylobacter infection. Emerg Infect Dis. 2003; 9(10):1219-25. PMC: 3033096. DOI: 10.3201/eid0910.020823. View

Effler P, Ieong M, Kimura A, Nakata M, Burr R, CREMER E . Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. J Infect Dis. 2001; 183(7):1152-5. DOI: 10.1086/319292. View

Unicomb L, Dalton C, Gilbert G, Becker N, Patel M . Age-specific risk factors for sporadic Campylobacter infection in regional Australia. Foodborne Pathog Dis. 2008; 5(1):79-85. DOI: 10.1089/fpd.2007.0047. View

Adak G, Cowden J, Nicholas S, EVANS H . The Public Health Laboratory Service national case-control study of primary indigenous sporadic cases of campylobacter infection. Epidemiol Infect. 1995; 115(1):15-22. PMC: 2271554. DOI: 10.1017/s0950268800058076. View

Michaud S, Menard S, Arbeit R . Campylobacteriosis, Eastern Townships, Quebec. Emerg Infect Dis. 2004; 10(10):1844-7. PMC: 3323265. DOI: 10.3201/eid1010.040228. View

Kapperud G, Skjerve E, Bean N, Ostroff S, Lassen J . Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol. 1992; 30(12):3117-21. PMC: 270598. DOI: 10.1128/jcm.30.12.3117-3121.1992. View

Tenkate T, Stafford R . Risk factors for campylobacter infection in infants and young children: a matched case-control study. Epidemiol Infect. 2002; 127(3):399-404. PMC: 2869763. DOI: 10.1017/s0950268801006306. View

Ikram R, Chambers S, Mitchell P, Brieseman M, Ikam O . A case control study to determine risk factors for campylobacter infection in Christchurch in the summer of 1992-3. N Z Med J. 1994; 107(988):430-2. View

10.

Studahl A, Andersson Y . Risk factors for indigenous campylobacter infection: a Swedish case-control study. Epidemiol Infect. 2000; 125(2):269-75. PMC: 2869598. DOI: 10.1017/s0950268899004562. View

11.

Neimann J, Engberg J, Molbak K, Wegener H . A case-control study of risk factors for sporadic campylobacter infections in Denmark. Epidemiol Infect. 2003; 130(3):353-66. PMC: 2869971. DOI: 10.1017/s0950268803008355. View

12.

Cole S, Hernan M, Robins J, Anastos K, Chmiel J, Detels R . Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003; 158(7):687-94. DOI: 10.1093/aje/kwg206. View

13.

Stafford R, Schluter P, Wilson A, Kirk M, Hall G, Unicomb L . Population-attributable risk estimates for risk factors associated with Campylobacter infection, australia. Emerg Infect Dis. 2008; 14(6):895-901. PMC: 2600281. DOI: 10.3201/eid1406.071008. View

14.

Gallay A, Bousquet V, Siret V, Prouzet-Mauleon V, De Valk H, Vaillant V . Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. J Infect Dis. 2008; 197(10):1477-84. DOI: 10.1086/587644. View

15.

Friedman C, Hoekstra R, Samuel M, Marcus R, Bender J, Shiferaw B . Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. Clin Infect Dis. 2004; 38 Suppl 3:S285-96. DOI: 10.1086/381598. View

16.

Rodrigues L, Cowden J, Wheeler J, Sethi D, Wall P, Cumberland P . The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect. 2001; 127(2):185-93. PMC: 2869737. DOI: 10.1017/s0950268801006057. View

17.

Wheeler J, Sethi D, Cowden J, Wall P, Rodrigues L, Tompkins D . Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ. 1999; 318(7190):1046-50. PMC: 27838. DOI: 10.1136/bmj.318.7190.1046. View

18.

Frost J, Gillespie I, OBrien S . Public health implications of campylobacter outbreaks in England and Wales, 1995-9: epidemiological and microbiological investigations. Epidemiol Infect. 2002; 128(2):111-8. PMC: 2869802. DOI: 10.1017/s0950268802006799. View

19.

Stafford R, Schluter P, Kirk M, Wilson A, Unicomb L, Ashbolt R . A multi-centre prospective case-control study of campylobacter infection in persons aged 5 years and older in Australia. Epidemiol Infect. 2006; 135(6):978-88. PMC: 2870644. DOI: 10.1017/S0950268806007576. View

20.

Wingstrand A, Neimann J, Engberg J, Nielsen E, Gerner-Smidt P, Wegener H . Fresh chicken as main risk factor for campylobacteriosis, Denmark. Emerg Infect Dis. 2006; 12(2):280-5. PMC: 3373097. DOI: 10.3201/eid1202.050936. View